【摘要】 男性冠心病患者20名,随机分成两组-气功治疗组和疾病对照组各10名。另年龄相近的健康男性10名作健康对照。所有对象均进行亚极量运动试验（功率车）前后血浆6-酮-PGF_α和血栓素B₂的测定.收缩间期则仅在安静时测定。疗程2个月,疗后复查以上指标。其结果为:1、安静时两组冠心病患者6-K-P含量及6-K-P/TXB₂比值均明显低于健康对照组,TXB₂则无明显差别。无论是冠心病组或健康对照组在亚极量运动后6-K-P,TXB₂及其比值均无明显影响。2、经一疗程气功治疗后,6-K-P和6-K-P/TXB₂明显增加,但对TXB₂无影响,疾病对照组则无改变。3、冠心病人安静时,QS₂I、PEPI和P/L均明显延长,经一疗程气功治疗后,PEPI及P/L有缩短倾向,但无统计学意义,其可能与病例较少,疗程较短有关,有待进一步观察。更多还原

【Abstract】 Twenty male CHD patients were equally divided into 2 groups at random,Qigong treatment group and control group. They recieved Qigong treatment and placebo resp-ectively. 10 appropriate health subjects were also studied. Plasma 6-keto-PGF1_α（6-K-P） andthromboxane B₂（TXB₂）（the metabolites of PGI₂ and TXA₂ respsctively） were measured byRIA in all subjects before and after submaximal exercise test on a cycle ergometer. The systolictime intervals （STI） were determined only at rest. After two months the test was repeated inall CHD patients. The results showed that 1) at rest plasma 6-K-P lever and 6-K-P/TXB2ratio of the CHD patients were significantly lower than those of health subjects, the plasmaTAB2 level were the same in the CHD patients and health subjects, neither health subjectsnor CHD patients had any changes in plasma 6-K-P, TXB2 level and 6-K-P/TXB2 ratioafter exercise. 2) Qigong treatment of one course （two months） could significantly increasethe plasma 6-K-P level （before exercise） and 6-K-P/TXB2 ratio but had no effects on theTXB2. 3) rest QS2I, PEPI and P/L were markedly prolonged in CHD patients, after onecourse of treatment, PEPI and P/L were reduced in Qigong treatment group but had no sta-tistic significance, this might be due to small sample and short treatment period and requiredfurther investigation.更多还原